2004201-300 peopleManufacturer/Wholesaler/Trading Company/Service Company
Established brand
OEM manufacturer
High-tech enterprise
Multinational enterprise
Shipments
40
Key customer
SINGAPORE GENEBIO
Key market
🇵🇭 Philippines
Description
Dat Vi Phu Pharmaceutical Joint Stock Company (Davipharm) is a prominent pharmaceutical manufacturer based in Vietnam, established in 2004. A member of the Adamed Group since 2017 and fully acquired in 2023, the company operates a high-standard manufacturing facility in Binh Duong with representative offices in Ho Chi Minh City and Hanoi. Davipharm is recognized for its commitment to quality, holding both WHO-GMP and EU-GMP certifications, and maintaining a certified High Potency (HP) Zone for specialized production.
Ryzonal
Artreil
Pexifen
SOARES
Arthur
LAKCAY
Gebhart
Gumas
Clobunil
Gellux
Ha Tay Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
1965501-1000 peopleManufacturer/Trading Company/Wholesaler/Distributor/Service Company
High capacity factory
Established brand
OEM manufacturer
Own brand
Shipments
2
Key customer
CANOPUS
Key market
🇻🇳 Vietnam
Description
Ha Tay Pharmaceutical Joint Stock Company (Hataphar), established in 1965 and headquartered in Hanoi, is a premier pharmaceutical manufacturer and distributor in Vietnam. Consistently ranked among the top 10 pharmaceutical enterprises in the country, the company operates as a publicly traded entity on the Hanoi Stock Exchange (HNX: DHT). With a workforce of over 780 employees, Hataphar specializes in the production, import, export, and distribution of a wide range of pharmaceutical products, including medicines, functional foods, cosmetics, medical equipment, and vaccines.
The company maintains a robust manufacturing infrastructure comprising three major facilities: a 17,000 sqm pharmaceutical factory, a 2,000 sqm supplement factory, and the advanced 45,000 sqm Hataphar High-Tech Pharmaceutical Factory. Demonstrating a commitment to international quality standards, Hataphar holds certifications for GMP-WHO, GLP, GSP, GDP, and GPP. Notably, through a strategic partnership with ASKA Pharmaceutical (Japan), the company has implemented PIC/s/Japan-GMP standards and is developing facilities to meet EU-GMP requirements for hormone-containing drugs and other specialized preparations.
Beyond its core manufacturing capabilities, Hataphar serves as a comprehensive B2B partner offering contract manufacturing (OEM/ODM), raw material trading, and import-export authorization services. The company manages an extensive distribution network covering all 63 provinces in Vietnam and sources high-quality raw materials from global markets, including France, Germany, Switzerland, and Japan. Its diverse portfolio includes recognized brands such as Augclamox, Zanmite, and Bosunamin, catering to both domestic and international healthcare needs.